)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Tate & Lyle
Tate & Lyle (TATE) investor relations material
Tate & Lyle H1 2027 (Q&A) earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2027 (Q&A) earnings summary5 Nov, 2026
Executive summary
H1 revenue grew 1% in constant currency, with volume/mix up 3%; adjusted EBITDA fell 8% to £197m, in line with expectations.
New business wins from solutions reached 58% by value, up 15 percentage points; like-for-like New Products revenue rose 4%.
FY27 guidance was maintained: modest revenue growth and broadly flat EBITDA before the c.US$20m bio-gums rescheduling impact.
Financial highlights
Revenue was £1,039m, up 1%; volume/mix grew 3%, partly offset by a 2% price decline.
Adjusted EBITDA was £197m, down 8%, and adjusted EBITDA margin fell 190bps to 19.0%.
Adjusted profit before tax fell 18% to £102m; adjusted EPS was 17.5p, down 17%.
Free cash flow was £100m versus £98m in H1 FY26; cash conversion was 75% versus 71%.
Productivity savings were US$27m in H1.
Outlook and guidance
FY27 constant-currency outlook remains modest revenue growth, with volume growth weighted to H2, and broadly flat EBITDA before the c.US$20m bio-gums rescheduling impact.
Cost inflation is expected to be passed through as 2027 customer framework agreements renew; procurement and operational discipline are planned offsets.
FY27 capital expenditure is expected to be £110m–£130m; adjusted effective tax rate guidance is 23%–25%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tate & Lyle
- Revenue growth returned, but adjusted EBITDA fell 8%; FY27 outlook was maintained.TATE
H1 2027 - Statutory revenue up 16%, but like-for-like results fell 3% amid muted demand.TATEH2 2026
- Q3 revenue rose 15% reported, but pro forma revenue fell 2%; outlook remains unchanged.TATEQ3 2026 TU
- Transformed specialty solutions leader targets 4%-6% revenue growth, leveraging CP Kelco synergies.TATECMD 2025
- EBITDA up 6%, cash flow strong, and strategic transformation completed.TATEH1 2025 (Q&A)
- EBITDA up 6% and margin expands as specialty strategy advances with CP Kelco and Primient sale.TATEH1 2025
- A $1.8B deal creates a global specialty food leader, targeting strong cost and revenue synergies.TATEBusiness Combination
- $1.8B deal creates a global specialty food leader with strong synergies and growth prospects.TATEBusiness Combination (Q&A)
- Volume and EBITDA growth, CP Kelco integration, and strong cash generation support future synergies.TATETrading Update
Next Tate & Lyle earnings date
H2 202720 May, 2027
Tate & Lyle
Next Tate & Lyle earnings date
H2 202720 May, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Tate & Lyle plc provides food and beverage ingredients and solutions, including sweeteners, texturants, and fiber enrichment products. The company serves manufacturers globally in sectors such as dairy, beverages, bakery, and nutrition, supporting product formulation and reformulation. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE.